NADAC acquisition cost data for ANAGRELIDE HCL 0.5 MG CAPSULE. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00172524160 | $0.7154 | 2022-06-22 | Rx |
| 13668045301 | $0.7154 | 2022-06-22 | Rx |
| 00172524160 | $0.7154 | 2022-06-22 | Rx |
| 13668045301 | $0.7154 | 2022-06-22 | Rx |
| 00172524160 | $0.7154 | 2022-06-22 | Rx |
| 13668045301 | $0.7154 | 2022-06-22 | Rx |
| 00172524160 | $0.7154 | 2022-06-22 | Rx |
| 13668045301 | $0.7154 | 2022-06-22 | Rx |
| 00172524160 | $0.7154 | 2022-06-22 | Rx |
| 13668045301 | $0.7154 | 2022-06-22 | Rx |
Generic: Anagrelide HCl | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $10.4M | 36,863 | 6,997 | $2.86 |
| 2020 | $11.8M | 26,197 | 5,564 | $4.70 |
| 2021 | $11.7M | 27,254 | 5,438 | $4.01 |
| 2022 | $10.0M | 27,587 | 5,492 | $3.28 |
| 2023 | $7.7M | 28,439 | 5,658 | $2.47 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.